nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—PPARG—systemic lupus erythematosus	0.113	0.556	CbGaD
Indomethacin—migraine—Prednisone—systemic lupus erythematosus	0.102	0.341	CpDpCtD
Indomethacin—osteoarthritis—Methylprednisolone—systemic lupus erythematosus	0.0991	0.33	CpDpCtD
Indomethacin—osteoarthritis—Prednisone—systemic lupus erythematosus	0.0991	0.33	CpDpCtD
Indomethacin—PTGS2—systemic lupus erythematosus	0.0477	0.235	CbGaD
Indomethacin—ALB—systemic lupus erythematosus	0.0425	0.209	CbGaD
Indomethacin—CES1—Mycophenolate mofetil—systemic lupus erythematosus	0.0253	0.0762	CbGbCtD
Indomethacin—ABCC11—Methotrexate—systemic lupus erythematosus	0.0244	0.0736	CbGbCtD
Indomethacin—SLC10A1—Cyclosporine—systemic lupus erythematosus	0.0229	0.0691	CbGbCtD
Indomethacin—UGT1A9—Mycophenolate mofetil—systemic lupus erythematosus	0.0153	0.0463	CbGbCtD
Indomethacin—UGT2B7—Mycophenolate mofetil—systemic lupus erythematosus	0.0145	0.0438	CbGbCtD
Indomethacin—ABCC3—Cyclosporine—systemic lupus erythematosus	0.0127	0.0384	CbGbCtD
Indomethacin—UGT1A1—Mycophenolate mofetil—systemic lupus erythematosus	0.0126	0.0378	CbGbCtD
Indomethacin—PTGS2—Dapsone—systemic lupus erythematosus	0.00871	0.0262	CbGbCtD
Indomethacin—SLCO1B1—Mycophenolate mofetil—systemic lupus erythematosus	0.00869	0.0262	CbGbCtD
Indomethacin—ABCC1—Cyclosporine—systemic lupus erythematosus	0.00782	0.0236	CbGbCtD
Indomethacin—SLCO1A2—Prednisolone—systemic lupus erythematosus	0.0078	0.0235	CbGbCtD
Indomethacin—ABCC2—Mycophenolate mofetil—systemic lupus erythematosus	0.00764	0.023	CbGbCtD
Indomethacin—PTGS2—Triamcinolone—systemic lupus erythematosus	0.00755	0.0228	CbGbCtD
Indomethacin—SLCO1A2—Hydrocortisone—systemic lupus erythematosus	0.00739	0.0223	CbGbCtD
Indomethacin—SLCO1A2—Prednisone—systemic lupus erythematosus	0.00737	0.0222	CbGbCtD
Indomethacin—PTGS1—Dapsone—systemic lupus erythematosus	0.00735	0.0222	CbGbCtD
Indomethacin—SLCO1A2—Cyclosporine—systemic lupus erythematosus	0.00698	0.021	CbGbCtD
Indomethacin—ABCC3—Methotrexate—systemic lupus erythematosus	0.00674	0.0203	CbGbCtD
Indomethacin—SLCO1B1—Cyclosporine—systemic lupus erythematosus	0.00659	0.0199	CbGbCtD
Indomethacin—PTGS2—Betamethasone—systemic lupus erythematosus	0.00648	0.0195	CbGbCtD
Indomethacin—ABCC2—Cyclosporine—systemic lupus erythematosus	0.00579	0.0174	CbGbCtD
Indomethacin—SLC22A11—Methotrexate—systemic lupus erythematosus	0.00553	0.0167	CbGbCtD
Indomethacin—SLC22A7—Methotrexate—systemic lupus erythematosus	0.00527	0.0159	CbGbCtD
Indomethacin—ABCC4—Methotrexate—systemic lupus erythematosus	0.00515	0.0155	CbGbCtD
Indomethacin—ALB—Mycophenolate mofetil—systemic lupus erythematosus	0.00476	0.0143	CbGbCtD
Indomethacin—SLCO1A2—Dexamethasone—systemic lupus erythematosus	0.0046	0.0139	CbGbCtD
Indomethacin—SLC22A6—Cyclosporine—systemic lupus erythematosus	0.00424	0.0128	CbGbCtD
Indomethacin—CYP2C9—Leflunomide—systemic lupus erythematosus	0.00415	0.0125	CbGbCtD
Indomethacin—ABCC1—Methotrexate—systemic lupus erythematosus	0.00414	0.0125	CbGbCtD
Indomethacin—PLA2G2A—synovial fluid—systemic lupus erythematosus	0.00397	0.0875	CbGeAlD
Indomethacin—ABCC2—Dexamethasone—systemic lupus erythematosus	0.00381	0.0115	CbGbCtD
Indomethacin—ALB—Prednisone—systemic lupus erythematosus	0.00381	0.0115	CbGbCtD
Indomethacin—PTGS2—Dexamethasone—systemic lupus erythematosus	0.00377	0.0114	CbGbCtD
Indomethacin—SLCO1A2—Methotrexate—systemic lupus erythematosus	0.0037	0.0111	CbGbCtD
Indomethacin—CYP2C19—Dapsone—systemic lupus erythematosus	0.00356	0.0107	CbGbCtD
Indomethacin—SLCO1B1—Methotrexate—systemic lupus erythematosus	0.00349	0.0105	CbGbCtD
Indomethacin—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.00329	0.0099	CbGbCtD
Indomethacin—SLC22A8—Methotrexate—systemic lupus erythematosus	0.00322	0.0097	CbGbCtD
Indomethacin—ABCC2—Methotrexate—systemic lupus erythematosus	0.00306	0.00923	CbGbCtD
Indomethacin—CYP2C9—Dapsone—systemic lupus erythematosus	0.00296	0.00892	CbGbCtD
Indomethacin—SLC22A8—choroid plexus—systemic lupus erythematosus	0.00267	0.0589	CbGeAlD
Indomethacin—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.00249	0.00751	CbGbCtD
Indomethacin—CYP2C19—Prednisone—systemic lupus erythematosus	0.00247	0.00744	CbGbCtD
Indomethacin—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.00234	0.00705	CbGbCtD
Indomethacin—SLC22A6—Methotrexate—systemic lupus erythematosus	0.00224	0.00676	CbGbCtD
Indomethacin—CYP2C9—cardial valve—systemic lupus erythematosus	0.00216	0.0475	CbGeAlD
Indomethacin—ABCB1—Betamethasone—systemic lupus erythematosus	0.00214	0.00644	CbGbCtD
Indomethacin—ABCB1—Prednisolone—systemic lupus erythematosus	0.00211	0.00635	CbGbCtD
Indomethacin—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.002	0.00602	CbGbCtD
Indomethacin—ABCB1—Prednisone—systemic lupus erythematosus	0.00199	0.006	CbGbCtD
Indomethacin—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.00194	0.00586	CbGbCtD
Indomethacin—ALB—Methotrexate—systemic lupus erythematosus	0.00191	0.00575	CbGbCtD
Indomethacin—ABCB1—Cyclosporine—systemic lupus erythematosus	0.00189	0.00569	CbGbCtD
Indomethacin—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.00154	0.00464	CbGbCtD
Indomethacin—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00128	0.00386	CbGbCtD
Indomethacin—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00124	0.00375	CbGbCtD
Indomethacin—UGT1A1—urine—systemic lupus erythematosus	0.00111	0.0244	CbGeAlD
Indomethacin—ABCB1—Methotrexate—systemic lupus erythematosus	0.000999	0.00301	CbGbCtD
Indomethacin—PLA2G2A—blood plasma—systemic lupus erythematosus	0.000807	0.0178	CbGeAlD
Indomethacin—ABCC6—blood plasma—systemic lupus erythematosus	0.000799	0.0176	CbGeAlD
Indomethacin—PTGDR2—tendon—systemic lupus erythematosus	0.000774	0.0171	CbGeAlD
Indomethacin—PPARA—blood plasma—systemic lupus erythematosus	0.000754	0.0166	CbGeAlD
Indomethacin—SLC22A8—urine—systemic lupus erythematosus	0.000715	0.0158	CbGeAlD
Indomethacin—PTGR2—kidney—systemic lupus erythematosus	0.000637	0.014	CbGeAlD
Indomethacin—PTGR2—cortex of kidney—systemic lupus erythematosus	0.00062	0.0137	CbGeAlD
Indomethacin—CYP2C19—urine—systemic lupus erythematosus	0.0006	0.0132	CbGeAlD
Indomethacin—UGT1A1—blood plasma—systemic lupus erythematosus	0.000577	0.0127	CbGeAlD
Indomethacin—PTGR2—tendon—systemic lupus erythematosus	0.000514	0.0113	CbGeAlD
Indomethacin—SLCO1B1—blood plasma—systemic lupus erythematosus	0.00048	0.0106	CbGeAlD
Indomethacin—PPARG—endothelium—systemic lupus erythematosus	0.000467	0.0103	CbGeAlD
Indomethacin—CYP2C9—urine—systemic lupus erythematosus	0.000465	0.0102	CbGeAlD
Indomethacin—ABCC3—blood plasma—systemic lupus erythematosus	0.000456	0.01	CbGeAlD
Indomethacin—PTGR2—lung—systemic lupus erythematosus	0.000451	0.00994	CbGeAlD
Indomethacin—GLO1—nephron tubule—systemic lupus erythematosus	0.000448	0.00987	CbGeAlD
Indomethacin—PLA2G2A—connective tissue—systemic lupus erythematosus	0.000429	0.00947	CbGeAlD
Indomethacin—ABCC6—connective tissue—systemic lupus erythematosus	0.000425	0.00937	CbGeAlD
Indomethacin—PTGR2—nervous system—systemic lupus erythematosus	0.000418	0.00921	CbGeAlD
Indomethacin—GLO1—skin of body—systemic lupus erythematosus	0.000417	0.0092	CbGeAlD
Indomethacin—PPARG—blood plasma—systemic lupus erythematosus	0.000414	0.00913	CbGeAlD
Indomethacin—CXCL8—nephron tubule—systemic lupus erythematosus	0.000412	0.00908	CbGeAlD
Indomethacin—PTGR2—central nervous system—systemic lupus erythematosus	0.000402	0.00887	CbGeAlD
Indomethacin—PPARA—connective tissue—systemic lupus erythematosus	0.000401	0.00884	CbGeAlD
Indomethacin—GLO1—kidney—systemic lupus erythematosus	0.000393	0.00867	CbGeAlD
Indomethacin—GLO1—cortex of kidney—systemic lupus erythematosus	0.000383	0.00844	CbGeAlD
Indomethacin—UGT1A9—kidney—systemic lupus erythematosus	0.000382	0.00842	CbGeAlD
Indomethacin—ABCC4—blood plasma—systemic lupus erythematosus	0.000376	0.00829	CbGeAlD
Indomethacin—PLA2G2A—kidney—systemic lupus erythematosus	0.000366	0.00806	CbGeAlD
Indomethacin—PPARA—skin of body—systemic lupus erythematosus	0.000362	0.00799	CbGeAlD
Indomethacin—ABCC6—kidney—systemic lupus erythematosus	0.000362	0.00798	CbGeAlD
Indomethacin—Bezafibrate—PPARG—systemic lupus erythematosus	0.000361	0.333	CrCbGaD
Indomethacin—PPARA—kidney—systemic lupus erythematosus	0.000342	0.00753	CbGeAlD
Indomethacin—SLC22A11—nephron tubule—systemic lupus erythematosus	0.000341	0.00752	CbGeAlD
Indomethacin—GLO1—lymphoid tissue—systemic lupus erythematosus	0.000338	0.00745	CbGeAlD
Indomethacin—SLC10A1—kidney—systemic lupus erythematosus	0.000328	0.00724	CbGeAlD
Indomethacin—AKR1C3—nephron tubule—systemic lupus erythematosus	0.000323	0.00712	CbGeAlD
Indomethacin—SLC22A6—nephron tubule—systemic lupus erythematosus	0.000322	0.00709	CbGeAlD
Indomethacin—GLO1—tendon—systemic lupus erythematosus	0.000318	0.007	CbGeAlD
Indomethacin—PLA2G2A—lymphoid tissue—systemic lupus erythematosus	0.000314	0.00692	CbGeAlD
Indomethacin—CYP2C19—blood plasma—systemic lupus erythematosus	0.000313	0.0069	CbGeAlD
Indomethacin—UGT2B7—kidney—systemic lupus erythematosus	0.000308	0.00678	CbGeAlD
Indomethacin—GLO1—bone marrow—systemic lupus erythematosus	0.000308	0.00678	CbGeAlD
Indomethacin—SLC22A11—kidney—systemic lupus erythematosus	0.0003	0.00661	CbGeAlD
Indomethacin—CES1—connective tissue—systemic lupus erythematosus	0.000298	0.00656	CbGeAlD
Indomethacin—PLA2G2A—tendon—systemic lupus erythematosus	0.000295	0.00651	CbGeAlD
Indomethacin—PPARA—lymphoid tissue—systemic lupus erythematosus	0.000293	0.00647	CbGeAlD
Indomethacin—SLC22A7—kidney—systemic lupus erythematosus	0.000293	0.00645	CbGeAlD
Indomethacin—SLC22A11—cortex of kidney—systemic lupus erythematosus	0.000292	0.00644	CbGeAlD
Indomethacin—SLC22A7—cortex of kidney—systemic lupus erythematosus	0.000285	0.00628	CbGeAlD
Indomethacin—CXCL8—bone marrow—systemic lupus erythematosus	0.000283	0.00624	CbGeAlD
Indomethacin—GLO1—lung—systemic lupus erythematosus	0.000279	0.00614	CbGeAlD
Indomethacin—AKR1C3—cortex of kidney—systemic lupus erythematosus	0.000276	0.00609	CbGeAlD
Indomethacin—Bromfenac—PTGS2—systemic lupus erythematosus	0.000276	0.254	CrCbGaD
Indomethacin—SLC22A6—cortex of kidney—systemic lupus erythematosus	0.000275	0.00607	CbGeAlD
Indomethacin—UGT1A1—kidney—systemic lupus erythematosus	0.000262	0.00577	CbGeAlD
Indomethacin—PLA2G2A—lung—systemic lupus erythematosus	0.000259	0.00571	CbGeAlD
Indomethacin—GLO1—nervous system—systemic lupus erythematosus	0.000258	0.00569	CbGeAlD
Indomethacin—ABCC6—lung—systemic lupus erythematosus	0.000256	0.00565	CbGeAlD
Indomethacin—CXCL8—lung—systemic lupus erythematosus	0.000256	0.00565	CbGeAlD
Indomethacin—PTGS1—endothelium—systemic lupus erythematosus	0.000249	0.0055	CbGeAlD
Indomethacin—GLO1—central nervous system—systemic lupus erythematosus	0.000248	0.00548	CbGeAlD
Indomethacin—CYP2C9—blood plasma—systemic lupus erythematosus	0.000243	0.00535	CbGeAlD
Indomethacin—PPARA—lung—systemic lupus erythematosus	0.000242	0.00533	CbGeAlD
Indomethacin—PLA2G2A—nervous system—systemic lupus erythematosus	0.00024	0.00529	CbGeAlD
Indomethacin—PTGS2—endothelium—systemic lupus erythematosus	0.000238	0.00526	CbGeAlD
Indomethacin—PLA2G2A—central nervous system—systemic lupus erythematosus	0.000231	0.00509	CbGeAlD
Indomethacin—AKR1C3—tendon—systemic lupus erythematosus	0.000229	0.00505	CbGeAlD
Indomethacin—PPARA—nervous system—systemic lupus erythematosus	0.000224	0.00494	CbGeAlD
Indomethacin—AKR1C3—bone marrow—systemic lupus erythematosus	0.000222	0.00489	CbGeAlD
Indomethacin—PTGS1—blood plasma—systemic lupus erythematosus	0.000222	0.00488	CbGeAlD
Indomethacin—PPARG—connective tissue—systemic lupus erythematosus	0.000221	0.00486	CbGeAlD
Indomethacin—SLCO1B1—kidney—systemic lupus erythematosus	0.000218	0.0048	CbGeAlD
Indomethacin—CES1—lymphoid tissue—systemic lupus erythematosus	0.000218	0.0048	CbGeAlD
Indomethacin—PPARA—central nervous system—systemic lupus erythematosus	0.000216	0.00476	CbGeAlD
Indomethacin—SLC10A1—nervous system—systemic lupus erythematosus	0.000215	0.00475	CbGeAlD
Indomethacin—PTGS2—blood plasma—systemic lupus erythematosus	0.000212	0.00467	CbGeAlD
Indomethacin—SLC10A1—central nervous system—systemic lupus erythematosus	0.000207	0.00457	CbGeAlD
Indomethacin—ABCC3—kidney—systemic lupus erythematosus	0.000207	0.00455	CbGeAlD
Indomethacin—AKR1C3—lung—systemic lupus erythematosus	0.000201	0.00443	CbGeAlD
Indomethacin—PPARG—skin of body—systemic lupus erythematosus	0.000199	0.00439	CbGeAlD
Indomethacin—ABCC4—nephron tubule—systemic lupus erythematosus	0.000194	0.00428	CbGeAlD
Indomethacin—SLC22A8—nephron tubule—systemic lupus erythematosus	0.000193	0.00424	CbGeAlD
Indomethacin—ABCC2—nephron tubule—systemic lupus erythematosus	0.000188	0.00414	CbGeAlD
Indomethacin—PPARG—kidney—systemic lupus erythematosus	0.000188	0.00414	CbGeAlD
Indomethacin—Tolmetin—PTGS2—systemic lupus erythematosus	0.000185	0.171	CrCbGaD
Indomethacin—PTGS2—Fluocinonide—Methylprednisolone—systemic lupus erythematosus	0.00018	0.159	CbGdCrCtD
Indomethacin—CES1—lung—systemic lupus erythematosus	0.00018	0.00396	CbGeAlD
Indomethacin—SLCO1A2—kidney—systemic lupus erythematosus	0.000177	0.00391	CbGeAlD
Indomethacin—PTGS2—Fluocinonide—Betamethasone—systemic lupus erythematosus	0.000177	0.156	CbGdCrCtD
Indomethacin—PTGS2—Fluocinonide—Dexamethasone—systemic lupus erythematosus	0.000177	0.156	CbGdCrCtD
Indomethacin—PTGS2—Fluocinonide—Triamcinolone—systemic lupus erythematosus	0.000173	0.153	CbGdCrCtD
Indomethacin—ABCC4—kidney—systemic lupus erythematosus	0.000171	0.00376	CbGeAlD
Indomethacin—SLC22A8—kidney—systemic lupus erythematosus	0.000169	0.00373	CbGeAlD
Indomethacin—CES1—nervous system—systemic lupus erythematosus	0.000166	0.00367	CbGeAlD
Indomethacin—ABCC4—cortex of kidney—systemic lupus erythematosus	0.000166	0.00366	CbGeAlD
Indomethacin—ABCC2—kidney—systemic lupus erythematosus	0.000165	0.00364	CbGeAlD
Indomethacin—SLC22A8—cortex of kidney—systemic lupus erythematosus	0.000165	0.00363	CbGeAlD
Indomethacin—PPARG—lymphoid tissue—systemic lupus erythematosus	0.000161	0.00356	CbGeAlD
Indomethacin—ABCC2—cortex of kidney—systemic lupus erythematosus	0.000161	0.00354	CbGeAlD
Indomethacin—CES1—central nervous system—systemic lupus erythematosus	0.00016	0.00353	CbGeAlD
Indomethacin—PPARG—tendon—systemic lupus erythematosus	0.000152	0.00334	CbGeAlD
Indomethacin—PPARG—bone marrow—systemic lupus erythematosus	0.000147	0.00324	CbGeAlD
Indomethacin—ABCC3—lung—systemic lupus erythematosus	0.000146	0.00323	CbGeAlD
Indomethacin—ABCC1—cortex of kidney—systemic lupus erythematosus	0.000142	0.00312	CbGeAlD
Indomethacin—Naproxen—PTGS2—systemic lupus erythematosus	0.000139	0.128	CrCbGaD
Indomethacin—ABCC4—tendon—systemic lupus erythematosus	0.000138	0.00304	CbGeAlD
Indomethacin—ABCC3—nervous system—systemic lupus erythematosus	0.000136	0.00299	CbGeAlD
Indomethacin—ABCC4—bone marrow—systemic lupus erythematosus	0.000133	0.00294	CbGeAlD
Indomethacin—ABCC2—tendon—systemic lupus erythematosus	0.000133	0.00294	CbGeAlD
Indomethacin—PPARG—lung—systemic lupus erythematosus	0.000133	0.00293	CbGeAlD
Indomethacin—ABCB1—blood plasma—systemic lupus erythematosus	0.000131	0.00289	CbGeAlD
Indomethacin—ABCC3—central nervous system—systemic lupus erythematosus	0.000131	0.00288	CbGeAlD
Indomethacin—SLCO1A2—lung—systemic lupus erythematosus	0.000126	0.00277	CbGeAlD
Indomethacin—Naproxen—ALB—systemic lupus erythematosus	0.000124	0.114	CrCbGaD
Indomethacin—PPARG—nervous system—systemic lupus erythematosus	0.000123	0.00272	CbGeAlD
Indomethacin—ABCC4—lung—systemic lupus erythematosus	0.000121	0.00266	CbGeAlD
Indomethacin—PPARG—central nervous system—systemic lupus erythematosus	0.000119	0.00262	CbGeAlD
Indomethacin—PTGS1—connective tissue—systemic lupus erythematosus	0.000118	0.0026	CbGeAlD
Indomethacin—ABCC1—tendon—systemic lupus erythematosus	0.000117	0.00259	CbGeAlD
Indomethacin—SLCO1A2—nervous system—systemic lupus erythematosus	0.000116	0.00256	CbGeAlD
Indomethacin—PTGS2—connective tissue—systemic lupus erythematosus	0.000113	0.00249	CbGeAlD
Indomethacin—SLCO1A2—central nervous system—systemic lupus erythematosus	0.000112	0.00247	CbGeAlD
Indomethacin—ABCC4—nervous system—systemic lupus erythematosus	0.000112	0.00247	CbGeAlD
Indomethacin—SLC22A8—nervous system—systemic lupus erythematosus	0.000111	0.00245	CbGeAlD
Indomethacin—PTGS2—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	0.000108	0.0958	CbGdCrCtD
Indomethacin—ABCC4—central nervous system—systemic lupus erythematosus	0.000108	0.00237	CbGeAlD
Indomethacin—SLC22A8—central nervous system—systemic lupus erythematosus	0.000107	0.00236	CbGeAlD
Indomethacin—PTGS2—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	0.000107	0.0942	CbGdCrCtD
Indomethacin—PTGS2—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	0.000107	0.0942	CbGdCrCtD
Indomethacin—PTGS1—skin of body—systemic lupus erythematosus	0.000106	0.00235	CbGeAlD
Indomethacin—PTGS2—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	0.000104	0.0921	CbGdCrCtD
Indomethacin—ABCC1—lung—systemic lupus erythematosus	0.000103	0.00227	CbGeAlD
Indomethacin—PTGS2—skin of body—systemic lupus erythematosus	0.000102	0.00224	CbGeAlD
Indomethacin—PTGS1—kidney—systemic lupus erythematosus	0.0001	0.00221	CbGeAlD
Indomethacin—PTGS2—kidney—systemic lupus erythematosus	9.6e-05	0.00212	CbGeAlD
Indomethacin—PTGS2—lymphoid tissue—systemic lupus erythematosus	8.24e-05	0.00182	CbGeAlD
Indomethacin—PTGS1—tendon—systemic lupus erythematosus	8.11e-05	0.00179	CbGeAlD
Indomethacin—PTGS2—tendon—systemic lupus erythematosus	7.75e-05	0.00171	CbGeAlD
Indomethacin—PTGS2—bone marrow—systemic lupus erythematosus	7.51e-05	0.00165	CbGeAlD
Indomethacin—PTGS1—lung—systemic lupus erythematosus	7.11e-05	0.00157	CbGeAlD
Indomethacin—PTGS2—lung—systemic lupus erythematosus	6.8e-05	0.0015	CbGeAlD
Indomethacin—ABCB1—nephron tubule—systemic lupus erythematosus	6.75e-05	0.00149	CbGeAlD
Indomethacin—PTGS1—nervous system—systemic lupus erythematosus	6.59e-05	0.00145	CbGeAlD
Indomethacin—PTGS1—central nervous system—systemic lupus erythematosus	6.34e-05	0.0014	CbGeAlD
Indomethacin—PTGS2—nervous system—systemic lupus erythematosus	6.3e-05	0.00139	CbGeAlD
Indomethacin—PTGS2—central nervous system—systemic lupus erythematosus	6.06e-05	0.00134	CbGeAlD
Indomethacin—ABCB1—kidney—systemic lupus erythematosus	5.94e-05	0.00131	CbGeAlD
Indomethacin—ABCB1—cortex of kidney—systemic lupus erythematosus	5.78e-05	0.00127	CbGeAlD
Indomethacin—ABCB1—lymphoid tissue—systemic lupus erythematosus	5.1e-05	0.00112	CbGeAlD
Indomethacin—ABCB1—bone marrow—systemic lupus erythematosus	4.64e-05	0.00102	CbGeAlD
Indomethacin—ABCB1—lung—systemic lupus erythematosus	4.21e-05	0.000927	CbGeAlD
Indomethacin—Tachycardia—Methylprednisolone—systemic lupus erythematosus	4.15e-05	0.000581	CcSEcCtD
Indomethacin—Headache—Leflunomide—systemic lupus erythematosus	4.13e-05	0.000579	CcSEcCtD
Indomethacin—Erythema—Prednisone—systemic lupus erythematosus	4.13e-05	0.000578	CcSEcCtD
Indomethacin—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	4.12e-05	0.000577	CcSEcCtD
Indomethacin—Agranulocytosis—Methotrexate—systemic lupus erythematosus	4.12e-05	0.000577	CcSEcCtD
Indomethacin—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	4.11e-05	0.000576	CcSEcCtD
Indomethacin—Convulsion—Dexamethasone—systemic lupus erythematosus	4.1e-05	0.000575	CcSEcCtD
Indomethacin—Convulsion—Betamethasone—systemic lupus erythematosus	4.1e-05	0.000575	CcSEcCtD
Indomethacin—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	4.09e-05	0.000573	CcSEcCtD
Indomethacin—Insomnia—Hydrocortisone—systemic lupus erythematosus	4.09e-05	0.000573	CcSEcCtD
Indomethacin—Hypertension—Dexamethasone—systemic lupus erythematosus	4.09e-05	0.000573	CcSEcCtD
Indomethacin—Hypertension—Betamethasone—systemic lupus erythematosus	4.09e-05	0.000573	CcSEcCtD
Indomethacin—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	4.06e-05	0.000569	CcSEcCtD
Indomethacin—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	4.06e-05	0.000569	CcSEcCtD
Indomethacin—Urticaria—Cyclosporine—systemic lupus erythematosus	4.05e-05	0.000567	CcSEcCtD
Indomethacin—Abdominal pain—Cyclosporine—systemic lupus erythematosus	4.03e-05	0.000564	CcSEcCtD
Indomethacin—Body temperature increased—Cyclosporine—systemic lupus erythematosus	4.03e-05	0.000564	CcSEcCtD
Indomethacin—Anxiety—Betamethasone—systemic lupus erythematosus	4.02e-05	0.000563	CcSEcCtD
Indomethacin—Anxiety—Dexamethasone—systemic lupus erythematosus	4.02e-05	0.000563	CcSEcCtD
Indomethacin—Discomfort—Dexamethasone—systemic lupus erythematosus	3.98e-05	0.000558	CcSEcCtD
Indomethacin—Discomfort—Betamethasone—systemic lupus erythematosus	3.98e-05	0.000558	CcSEcCtD
Indomethacin—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	3.98e-05	0.000558	CcSEcCtD
Indomethacin—Haemoglobin—Methotrexate—systemic lupus erythematosus	3.98e-05	0.000558	CcSEcCtD
Indomethacin—Hypotension—Methylprednisolone—systemic lupus erythematosus	3.97e-05	0.000556	CcSEcCtD
Indomethacin—Pain—Prednisolone—systemic lupus erythematosus	3.96e-05	0.000555	CcSEcCtD
Indomethacin—Haemorrhage—Methotrexate—systemic lupus erythematosus	3.96e-05	0.000555	CcSEcCtD
Indomethacin—Hepatitis—Methotrexate—systemic lupus erythematosus	3.96e-05	0.000555	CcSEcCtD
Indomethacin—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	3.95e-05	0.000553	CcSEcCtD
Indomethacin—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	3.93e-05	0.000551	CcSEcCtD
Indomethacin—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	3.93e-05	0.00055	CcSEcCtD
Indomethacin—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	3.93e-05	0.00055	CcSEcCtD
Indomethacin—Nausea—Leflunomide—systemic lupus erythematosus	3.92e-05	0.000549	CcSEcCtD
Indomethacin—Fatigue—Hydrocortisone—systemic lupus erythematosus	3.9e-05	0.000546	CcSEcCtD
Indomethacin—ABCB1—nervous system—systemic lupus erythematosus	3.89e-05	0.000859	CbGeAlD
Indomethacin—Vision blurred—Prednisone—systemic lupus erythematosus	3.89e-05	0.000545	CcSEcCtD
Indomethacin—Pain—Hydrocortisone—systemic lupus erythematosus	3.87e-05	0.000542	CcSEcCtD
Indomethacin—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	3.87e-05	0.000542	CcSEcCtD
Indomethacin—Oedema—Betamethasone—systemic lupus erythematosus	3.87e-05	0.000542	CcSEcCtD
Indomethacin—Oedema—Dexamethasone—systemic lupus erythematosus	3.87e-05	0.000542	CcSEcCtD
Indomethacin—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	3.87e-05	0.000542	CcSEcCtD
Indomethacin—Insomnia—Triamcinolone—systemic lupus erythematosus	3.85e-05	0.00054	CcSEcCtD
Indomethacin—Insomnia—Methylprednisolone—systemic lupus erythematosus	3.85e-05	0.000539	CcSEcCtD
Indomethacin—Ill-defined disorder—Prednisone—systemic lupus erythematosus	3.83e-05	0.000536	CcSEcCtD
Indomethacin—Paraesthesia—Triamcinolone—systemic lupus erythematosus	3.83e-05	0.000536	CcSEcCtD
Indomethacin—Feeling abnormal—Prednisolone—systemic lupus erythematosus	3.82e-05	0.000535	CcSEcCtD
Indomethacin—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	3.82e-05	0.000535	CcSEcCtD
Indomethacin—Anaemia—Prednisone—systemic lupus erythematosus	3.81e-05	0.000534	CcSEcCtD
Indomethacin—Shock—Betamethasone—systemic lupus erythematosus	3.8e-05	0.000533	CcSEcCtD
Indomethacin—Shock—Dexamethasone—systemic lupus erythematosus	3.8e-05	0.000533	CcSEcCtD
Indomethacin—Dyspnoea—Triamcinolone—systemic lupus erythematosus	3.8e-05	0.000532	CcSEcCtD
Indomethacin—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	3.79e-05	0.00053	CcSEcCtD
Indomethacin—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	3.79e-05	0.00053	CcSEcCtD
Indomethacin—Tachycardia—Dexamethasone—systemic lupus erythematosus	3.77e-05	0.000529	CcSEcCtD
Indomethacin—Tachycardia—Betamethasone—systemic lupus erythematosus	3.77e-05	0.000529	CcSEcCtD
Indomethacin—Angioedema—Prednisone—systemic lupus erythematosus	3.77e-05	0.000528	CcSEcCtD
Indomethacin—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	3.75e-05	0.000525	CcSEcCtD
Indomethacin—Dyspepsia—Triamcinolone—systemic lupus erythematosus	3.75e-05	0.000525	CcSEcCtD
Indomethacin—ABCB1—central nervous system—systemic lupus erythematosus	3.75e-05	0.000827	CbGeAlD
Indomethacin—Erythema multiforme—Methotrexate—systemic lupus erythematosus	3.74e-05	0.000525	CcSEcCtD
Indomethacin—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	3.74e-05	0.000524	CcSEcCtD
Indomethacin—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	3.74e-05	0.000524	CcSEcCtD
Indomethacin—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	3.74e-05	0.000524	CcSEcCtD
Indomethacin—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	3.73e-05	0.000522	CcSEcCtD
Indomethacin—Malaise—Prednisone—systemic lupus erythematosus	3.72e-05	0.000521	CcSEcCtD
Indomethacin—Vertigo—Prednisone—systemic lupus erythematosus	3.71e-05	0.000519	CcSEcCtD
Indomethacin—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	3.7e-05	0.000518	CcSEcCtD
Indomethacin—Syncope—Prednisone—systemic lupus erythematosus	3.7e-05	0.000518	CcSEcCtD
Indomethacin—Tinnitus—Methotrexate—systemic lupus erythematosus	3.69e-05	0.000517	CcSEcCtD
Indomethacin—Anorexia—Dexamethasone—systemic lupus erythematosus	3.69e-05	0.000516	CcSEcCtD
Indomethacin—Anorexia—Betamethasone—systemic lupus erythematosus	3.69e-05	0.000516	CcSEcCtD
Indomethacin—Urticaria—Prednisolone—systemic lupus erythematosus	3.68e-05	0.000516	CcSEcCtD
Indomethacin—Fatigue—Triamcinolone—systemic lupus erythematosus	3.67e-05	0.000515	CcSEcCtD
Indomethacin—Fatigue—Methylprednisolone—systemic lupus erythematosus	3.67e-05	0.000513	CcSEcCtD
Indomethacin—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	3.66e-05	0.000513	CcSEcCtD
Indomethacin—Asthenia—Cyclosporine—systemic lupus erythematosus	3.65e-05	0.000512	CcSEcCtD
Indomethacin—Pain—Triamcinolone—systemic lupus erythematosus	3.64e-05	0.00051	CcSEcCtD
Indomethacin—Loss of consciousness—Prednisone—systemic lupus erythematosus	3.63e-05	0.000508	CcSEcCtD
Indomethacin—Hypotension—Dexamethasone—systemic lupus erythematosus	3.61e-05	0.000506	CcSEcCtD
Indomethacin—Hypotension—Betamethasone—systemic lupus erythematosus	3.61e-05	0.000506	CcSEcCtD
Indomethacin—Pruritus—Cyclosporine—systemic lupus erythematosus	3.6e-05	0.000505	CcSEcCtD
Indomethacin—Urticaria—Hydrocortisone—systemic lupus erythematosus	3.59e-05	0.000504	CcSEcCtD
Indomethacin—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	3.58e-05	0.000501	CcSEcCtD
Indomethacin—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	3.58e-05	0.000501	CcSEcCtD
Indomethacin—Convulsion—Prednisone—systemic lupus erythematosus	3.57e-05	0.000501	CcSEcCtD
Indomethacin—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	3.56e-05	0.000499	CcSEcCtD
Indomethacin—Hypertension—Prednisone—systemic lupus erythematosus	3.56e-05	0.000499	CcSEcCtD
Indomethacin—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	3.51e-05	0.000492	CcSEcCtD
Indomethacin—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	3.51e-05	0.000492	CcSEcCtD
Indomethacin—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	3.5e-05	0.000491	CcSEcCtD
Indomethacin—Anxiety—Prednisone—systemic lupus erythematosus	3.5e-05	0.00049	CcSEcCtD
Indomethacin—Alopecia—Methotrexate—systemic lupus erythematosus	3.5e-05	0.00049	CcSEcCtD
Indomethacin—Insomnia—Betamethasone—systemic lupus erythematosus	3.5e-05	0.00049	CcSEcCtD
Indomethacin—Insomnia—Dexamethasone—systemic lupus erythematosus	3.5e-05	0.00049	CcSEcCtD
Indomethacin—Diarrhoea—Cyclosporine—systemic lupus erythematosus	3.48e-05	0.000488	CcSEcCtD
Indomethacin—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	3.48e-05	0.000487	CcSEcCtD
Indomethacin—Paraesthesia—Dexamethasone—systemic lupus erythematosus	3.47e-05	0.000486	CcSEcCtD
Indomethacin—Paraesthesia—Betamethasone—systemic lupus erythematosus	3.47e-05	0.000486	CcSEcCtD
Indomethacin—Discomfort—Prednisone—systemic lupus erythematosus	3.47e-05	0.000486	CcSEcCtD
Indomethacin—Erythema—Methotrexate—systemic lupus erythematosus	3.45e-05	0.000483	CcSEcCtD
Indomethacin—Hypersensitivity—Prednisolone—systemic lupus erythematosus	3.41e-05	0.000478	CcSEcCtD
Indomethacin—Dyspepsia—Betamethasone—systemic lupus erythematosus	3.4e-05	0.000477	CcSEcCtD
Indomethacin—Dyspepsia—Dexamethasone—systemic lupus erythematosus	3.4e-05	0.000477	CcSEcCtD
Indomethacin—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	3.4e-05	0.000476	CcSEcCtD
Indomethacin—Urticaria—Triamcinolone—systemic lupus erythematosus	3.39e-05	0.000474	CcSEcCtD
Indomethacin—Urticaria—Methylprednisolone—systemic lupus erythematosus	3.38e-05	0.000473	CcSEcCtD
Indomethacin—Body temperature increased—Triamcinolone—systemic lupus erythematosus	3.37e-05	0.000472	CcSEcCtD
Indomethacin—Dizziness—Cyclosporine—systemic lupus erythematosus	3.37e-05	0.000472	CcSEcCtD
Indomethacin—Anaphylactic shock—Prednisone—systemic lupus erythematosus	3.37e-05	0.000472	CcSEcCtD
Indomethacin—Oedema—Prednisone—systemic lupus erythematosus	3.37e-05	0.000472	CcSEcCtD
Indomethacin—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	3.36e-05	0.000471	CcSEcCtD
Indomethacin—Decreased appetite—Dexamethasone—systemic lupus erythematosus	3.36e-05	0.000471	CcSEcCtD
Indomethacin—Decreased appetite—Betamethasone—systemic lupus erythematosus	3.36e-05	0.000471	CcSEcCtD
Indomethacin—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	3.33e-05	0.000467	CcSEcCtD
Indomethacin—Fatigue—Dexamethasone—systemic lupus erythematosus	3.33e-05	0.000467	CcSEcCtD
Indomethacin—Fatigue—Betamethasone—systemic lupus erythematosus	3.33e-05	0.000467	CcSEcCtD
Indomethacin—Shock—Prednisone—systemic lupus erythematosus	3.31e-05	0.000464	CcSEcCtD
Indomethacin—Pain—Dexamethasone—systemic lupus erythematosus	3.31e-05	0.000463	CcSEcCtD
Indomethacin—Pain—Betamethasone—systemic lupus erythematosus	3.31e-05	0.000463	CcSEcCtD
Indomethacin—Tachycardia—Prednisone—systemic lupus erythematosus	3.29e-05	0.00046	CcSEcCtD
Indomethacin—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	3.28e-05	0.00046	CcSEcCtD
Indomethacin—Hyperhidrosis—Prednisone—systemic lupus erythematosus	3.25e-05	0.000456	CcSEcCtD
Indomethacin—Vision blurred—Methotrexate—systemic lupus erythematosus	3.25e-05	0.000455	CcSEcCtD
Indomethacin—Asthenia—Hydrocortisone—systemic lupus erythematosus	3.25e-05	0.000455	CcSEcCtD
Indomethacin—Vomiting—Cyclosporine—systemic lupus erythematosus	3.24e-05	0.000453	CcSEcCtD
Indomethacin—Rash—Cyclosporine—systemic lupus erythematosus	3.21e-05	0.00045	CcSEcCtD
Indomethacin—Anorexia—Prednisone—systemic lupus erythematosus	3.21e-05	0.00045	CcSEcCtD
Indomethacin—Dermatitis—Cyclosporine—systemic lupus erythematosus	3.21e-05	0.000449	CcSEcCtD
Indomethacin—Pruritus—Hydrocortisone—systemic lupus erythematosus	3.2e-05	0.000448	CcSEcCtD
Indomethacin—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	3.2e-05	0.000448	CcSEcCtD
Indomethacin—Headache—Cyclosporine—systemic lupus erythematosus	3.19e-05	0.000447	CcSEcCtD
Indomethacin—Anaemia—Methotrexate—systemic lupus erythematosus	3.19e-05	0.000446	CcSEcCtD
Indomethacin—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	3.19e-05	0.000446	CcSEcCtD
Indomethacin—Feeling abnormal—Betamethasone—systemic lupus erythematosus	3.19e-05	0.000446	CcSEcCtD
Indomethacin—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	3.16e-05	0.000443	CcSEcCtD
Indomethacin—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	3.16e-05	0.000443	CcSEcCtD
Indomethacin—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	3.16e-05	0.000442	CcSEcCtD
Indomethacin—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	3.14e-05	0.00044	CcSEcCtD
Indomethacin—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	3.13e-05	0.000439	CcSEcCtD
Indomethacin—Rash—Mycophenolate mofetil—systemic lupus erythematosus	3.13e-05	0.000439	CcSEcCtD
Indomethacin—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	3.13e-05	0.000438	CcSEcCtD
Indomethacin—Headache—Mycophenolate mofetil—systemic lupus erythematosus	3.11e-05	0.000436	CcSEcCtD
Indomethacin—Malaise—Methotrexate—systemic lupus erythematosus	3.11e-05	0.000436	CcSEcCtD
Indomethacin—Vertigo—Methotrexate—systemic lupus erythematosus	3.1e-05	0.000434	CcSEcCtD
Indomethacin—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	3.1e-05	0.000434	CcSEcCtD
Indomethacin—Leukopenia—Methotrexate—systemic lupus erythematosus	3.09e-05	0.000432	CcSEcCtD
Indomethacin—Urticaria—Betamethasone—systemic lupus erythematosus	3.07e-05	0.00043	CcSEcCtD
Indomethacin—Urticaria—Dexamethasone—systemic lupus erythematosus	3.07e-05	0.00043	CcSEcCtD
Indomethacin—Dizziness—Prednisolone—systemic lupus erythematosus	3.06e-05	0.000429	CcSEcCtD
Indomethacin—Asthenia—Triamcinolone—systemic lupus erythematosus	3.06e-05	0.000428	CcSEcCtD
Indomethacin—Abdominal pain—Betamethasone—systemic lupus erythematosus	3.06e-05	0.000428	CcSEcCtD
Indomethacin—Abdominal pain—Dexamethasone—systemic lupus erythematosus	3.06e-05	0.000428	CcSEcCtD
Indomethacin—Body temperature increased—Betamethasone—systemic lupus erythematosus	3.06e-05	0.000428	CcSEcCtD
Indomethacin—Body temperature increased—Dexamethasone—systemic lupus erythematosus	3.06e-05	0.000428	CcSEcCtD
Indomethacin—Asthenia—Methylprednisolone—systemic lupus erythematosus	3.05e-05	0.000427	CcSEcCtD
Indomethacin—Insomnia—Prednisone—systemic lupus erythematosus	3.05e-05	0.000427	CcSEcCtD
Indomethacin—Nausea—Cyclosporine—systemic lupus erythematosus	3.02e-05	0.000424	CcSEcCtD
Indomethacin—Paraesthesia—Prednisone—systemic lupus erythematosus	3.02e-05	0.000423	CcSEcCtD
Indomethacin—Pruritus—Triamcinolone—systemic lupus erythematosus	3.01e-05	0.000422	CcSEcCtD
Indomethacin—Pruritus—Methylprednisolone—systemic lupus erythematosus	3.01e-05	0.000421	CcSEcCtD
Indomethacin—Dizziness—Hydrocortisone—systemic lupus erythematosus	2.99e-05	0.000419	CcSEcCtD
Indomethacin—Convulsion—Methotrexate—systemic lupus erythematosus	2.99e-05	0.000418	CcSEcCtD
Indomethacin—Dyspepsia—Prednisone—systemic lupus erythematosus	2.96e-05	0.000415	CcSEcCtD
Indomethacin—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	2.95e-05	0.000413	CcSEcCtD
Indomethacin—Chest pain—Methotrexate—systemic lupus erythematosus	2.94e-05	0.000411	CcSEcCtD
Indomethacin—Decreased appetite—Prednisone—systemic lupus erythematosus	2.93e-05	0.00041	CcSEcCtD
Indomethacin—Rash—Prednisolone—systemic lupus erythematosus	2.92e-05	0.000409	CcSEcCtD
Indomethacin—Dermatitis—Prednisolone—systemic lupus erythematosus	2.92e-05	0.000409	CcSEcCtD
Indomethacin—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	2.91e-05	0.000407	CcSEcCtD
Indomethacin—Fatigue—Prednisone—systemic lupus erythematosus	2.9e-05	0.000407	CcSEcCtD
Indomethacin—Headache—Prednisolone—systemic lupus erythematosus	2.9e-05	0.000407	CcSEcCtD
Indomethacin—Discomfort—Methotrexate—systemic lupus erythematosus	2.9e-05	0.000406	CcSEcCtD
Indomethacin—Constipation—Prednisone—systemic lupus erythematosus	2.88e-05	0.000403	CcSEcCtD
Indomethacin—Vomiting—Hydrocortisone—systemic lupus erythematosus	2.88e-05	0.000403	CcSEcCtD
Indomethacin—Rash—Hydrocortisone—systemic lupus erythematosus	2.85e-05	0.0004	CcSEcCtD
Indomethacin—Dermatitis—Hydrocortisone—systemic lupus erythematosus	2.85e-05	0.000399	CcSEcCtD
Indomethacin—Confusional state—Methotrexate—systemic lupus erythematosus	2.84e-05	0.000397	CcSEcCtD
Indomethacin—Headache—Hydrocortisone—systemic lupus erythematosus	2.83e-05	0.000397	CcSEcCtD
Indomethacin—Dizziness—Triamcinolone—systemic lupus erythematosus	2.82e-05	0.000395	CcSEcCtD
Indomethacin—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	2.81e-05	0.000394	CcSEcCtD
Indomethacin—Dizziness—Methylprednisolone—systemic lupus erythematosus	2.81e-05	0.000394	CcSEcCtD
Indomethacin—Feeling abnormal—Prednisone—systemic lupus erythematosus	2.77e-05	0.000389	CcSEcCtD
Indomethacin—Asthenia—Betamethasone—systemic lupus erythematosus	2.77e-05	0.000389	CcSEcCtD
Indomethacin—Asthenia—Dexamethasone—systemic lupus erythematosus	2.77e-05	0.000389	CcSEcCtD
Indomethacin—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	2.76e-05	0.000386	CcSEcCtD
Indomethacin—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	2.75e-05	0.000386	CcSEcCtD
Indomethacin—Nausea—Prednisolone—systemic lupus erythematosus	2.75e-05	0.000386	CcSEcCtD
Indomethacin—Pruritus—Betamethasone—systemic lupus erythematosus	2.74e-05	0.000383	CcSEcCtD
Indomethacin—Pruritus—Dexamethasone—systemic lupus erythematosus	2.74e-05	0.000383	CcSEcCtD
Indomethacin—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	2.72e-05	0.000381	CcSEcCtD
Indomethacin—Vomiting—Triamcinolone—systemic lupus erythematosus	2.71e-05	0.000379	CcSEcCtD
Indomethacin—Vomiting—Methylprednisolone—systemic lupus erythematosus	2.7e-05	0.000379	CcSEcCtD
Indomethacin—Nausea—Hydrocortisone—systemic lupus erythematosus	2.69e-05	0.000377	CcSEcCtD
Indomethacin—Rash—Triamcinolone—systemic lupus erythematosus	2.69e-05	0.000376	CcSEcCtD
Indomethacin—Dermatitis—Triamcinolone—systemic lupus erythematosus	2.68e-05	0.000376	CcSEcCtD
Indomethacin—Anorexia—Methotrexate—systemic lupus erythematosus	2.68e-05	0.000376	CcSEcCtD
Indomethacin—Rash—Methylprednisolone—systemic lupus erythematosus	2.68e-05	0.000375	CcSEcCtD
Indomethacin—Dermatitis—Methylprednisolone—systemic lupus erythematosus	2.68e-05	0.000375	CcSEcCtD
Indomethacin—Urticaria—Prednisone—systemic lupus erythematosus	2.67e-05	0.000375	CcSEcCtD
Indomethacin—Headache—Triamcinolone—systemic lupus erythematosus	2.67e-05	0.000374	CcSEcCtD
Indomethacin—Headache—Methylprednisolone—systemic lupus erythematosus	2.66e-05	0.000373	CcSEcCtD
Indomethacin—Body temperature increased—Prednisone—systemic lupus erythematosus	2.66e-05	0.000373	CcSEcCtD
Indomethacin—Abdominal pain—Prednisone—systemic lupus erythematosus	2.66e-05	0.000373	CcSEcCtD
Indomethacin—Diarrhoea—Dexamethasone—systemic lupus erythematosus	2.65e-05	0.000371	CcSEcCtD
Indomethacin—Diarrhoea—Betamethasone—systemic lupus erythematosus	2.65e-05	0.000371	CcSEcCtD
Indomethacin—Hypotension—Methotrexate—systemic lupus erythematosus	2.63e-05	0.000368	CcSEcCtD
Indomethacin—Dizziness—Betamethasone—systemic lupus erythematosus	2.56e-05	0.000358	CcSEcCtD
Indomethacin—Dizziness—Dexamethasone—systemic lupus erythematosus	2.56e-05	0.000358	CcSEcCtD
Indomethacin—Insomnia—Methotrexate—systemic lupus erythematosus	2.55e-05	0.000356	CcSEcCtD
Indomethacin—Nausea—Triamcinolone—systemic lupus erythematosus	2.53e-05	0.000355	CcSEcCtD
Indomethacin—Paraesthesia—Methotrexate—systemic lupus erythematosus	2.53e-05	0.000354	CcSEcCtD
Indomethacin—Nausea—Methylprednisolone—systemic lupus erythematosus	2.53e-05	0.000354	CcSEcCtD
Indomethacin—Dyspnoea—Methotrexate—systemic lupus erythematosus	2.51e-05	0.000351	CcSEcCtD
Indomethacin—Somnolence—Methotrexate—systemic lupus erythematosus	2.5e-05	0.00035	CcSEcCtD
Indomethacin—Hypersensitivity—Prednisone—systemic lupus erythematosus	2.48e-05	0.000347	CcSEcCtD
Indomethacin—Dyspepsia—Methotrexate—systemic lupus erythematosus	2.48e-05	0.000347	CcSEcCtD
Indomethacin—Vomiting—Dexamethasone—systemic lupus erythematosus	2.46e-05	0.000344	CcSEcCtD
Indomethacin—Vomiting—Betamethasone—systemic lupus erythematosus	2.46e-05	0.000344	CcSEcCtD
Indomethacin—Decreased appetite—Methotrexate—systemic lupus erythematosus	2.45e-05	0.000343	CcSEcCtD
Indomethacin—Rash—Betamethasone—systemic lupus erythematosus	2.44e-05	0.000341	CcSEcCtD
Indomethacin—Rash—Dexamethasone—systemic lupus erythematosus	2.44e-05	0.000341	CcSEcCtD
Indomethacin—Dermatitis—Betamethasone—systemic lupus erythematosus	2.44e-05	0.000341	CcSEcCtD
Indomethacin—Dermatitis—Dexamethasone—systemic lupus erythematosus	2.44e-05	0.000341	CcSEcCtD
Indomethacin—Fatigue—Methotrexate—systemic lupus erythematosus	2.43e-05	0.00034	CcSEcCtD
Indomethacin—Headache—Betamethasone—systemic lupus erythematosus	2.42e-05	0.000339	CcSEcCtD
Indomethacin—Headache—Dexamethasone—systemic lupus erythematosus	2.42e-05	0.000339	CcSEcCtD
Indomethacin—Asthenia—Prednisone—systemic lupus erythematosus	2.42e-05	0.000338	CcSEcCtD
Indomethacin—Pain—Methotrexate—systemic lupus erythematosus	2.41e-05	0.000337	CcSEcCtD
Indomethacin—Pruritus—Prednisone—systemic lupus erythematosus	2.38e-05	0.000334	CcSEcCtD
Indomethacin—Feeling abnormal—Methotrexate—systemic lupus erythematosus	2.32e-05	0.000325	CcSEcCtD
Indomethacin—Diarrhoea—Prednisone—systemic lupus erythematosus	2.3e-05	0.000323	CcSEcCtD
Indomethacin—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	2.3e-05	0.000322	CcSEcCtD
Indomethacin—Nausea—Dexamethasone—systemic lupus erythematosus	2.3e-05	0.000322	CcSEcCtD
Indomethacin—Nausea—Betamethasone—systemic lupus erythematosus	2.3e-05	0.000322	CcSEcCtD
Indomethacin—Urticaria—Methotrexate—systemic lupus erythematosus	2.24e-05	0.000313	CcSEcCtD
Indomethacin—Dizziness—Prednisone—systemic lupus erythematosus	2.23e-05	0.000312	CcSEcCtD
Indomethacin—Abdominal pain—Methotrexate—systemic lupus erythematosus	2.22e-05	0.000312	CcSEcCtD
Indomethacin—Body temperature increased—Methotrexate—systemic lupus erythematosus	2.22e-05	0.000312	CcSEcCtD
Indomethacin—Vomiting—Prednisone—systemic lupus erythematosus	2.14e-05	0.0003	CcSEcCtD
Indomethacin—Rash—Prednisone—systemic lupus erythematosus	2.12e-05	0.000297	CcSEcCtD
Indomethacin—Dermatitis—Prednisone—systemic lupus erythematosus	2.12e-05	0.000297	CcSEcCtD
Indomethacin—Headache—Prednisone—systemic lupus erythematosus	2.11e-05	0.000295	CcSEcCtD
Indomethacin—Hypersensitivity—Methotrexate—systemic lupus erythematosus	2.07e-05	0.00029	CcSEcCtD
Indomethacin—Asthenia—Methotrexate—systemic lupus erythematosus	2.02e-05	0.000283	CcSEcCtD
Indomethacin—Nausea—Prednisone—systemic lupus erythematosus	2e-05	0.00028	CcSEcCtD
Indomethacin—Pruritus—Methotrexate—systemic lupus erythematosus	1.99e-05	0.000279	CcSEcCtD
Indomethacin—Diarrhoea—Methotrexate—systemic lupus erythematosus	1.93e-05	0.00027	CcSEcCtD
Indomethacin—Dizziness—Methotrexate—systemic lupus erythematosus	1.86e-05	0.000261	CcSEcCtD
Indomethacin—Vomiting—Methotrexate—systemic lupus erythematosus	1.79e-05	0.000251	CcSEcCtD
Indomethacin—Rash—Methotrexate—systemic lupus erythematosus	1.77e-05	0.000249	CcSEcCtD
Indomethacin—Dermatitis—Methotrexate—systemic lupus erythematosus	1.77e-05	0.000248	CcSEcCtD
Indomethacin—Headache—Methotrexate—systemic lupus erythematosus	1.76e-05	0.000247	CcSEcCtD
Indomethacin—Nausea—Methotrexate—systemic lupus erythematosus	1.67e-05	0.000234	CcSEcCtD
Indomethacin—PTGS2—Disease—HIST2H2AC—systemic lupus erythematosus	5.36e-06	0.000118	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	5.31e-06	0.000117	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CCR5—systemic lupus erythematosus	5.3e-06	0.000117	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.27e-06	0.000116	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—TYK2—systemic lupus erythematosus	5.26e-06	0.000116	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—ALB—systemic lupus erythematosus	5.26e-06	0.000116	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—RXRA—systemic lupus erythematosus	5.23e-06	0.000115	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—RXRA—systemic lupus erythematosus	5.23e-06	0.000115	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.23e-06	0.000115	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.22e-06	0.000115	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CSK—systemic lupus erythematosus	5.22e-06	0.000115	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	5.21e-06	0.000115	CbGpPWpGaD
Indomethacin—SLC22A6—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	5.19e-06	0.000114	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—NR3C1—systemic lupus erythematosus	5.19e-06	0.000114	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—C3—systemic lupus erythematosus	5.18e-06	0.000114	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—NOS3—systemic lupus erythematosus	5.16e-06	0.000114	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PRL—systemic lupus erythematosus	5.15e-06	0.000113	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—EP300—systemic lupus erythematosus	5.14e-06	0.000113	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	5.08e-06	0.000112	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—NOS3—systemic lupus erythematosus	5.03e-06	0.000111	CbGpPWpGaD
Indomethacin—ABCC2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	5.03e-06	0.000111	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PPARG—systemic lupus erythematosus	5.03e-06	0.000111	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—EP300—systemic lupus erythematosus	5.01e-06	0.00011	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	5e-06	0.00011	CbGpPWpGaD
Indomethacin—ABCC1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	4.97e-06	0.000109	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.97e-06	0.000109	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	4.96e-06	0.000109	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—RXRA—systemic lupus erythematosus	4.95e-06	0.000109	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	4.93e-06	0.000109	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—TYK2—systemic lupus erythematosus	4.92e-06	0.000108	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.91e-06	0.000108	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CD247—systemic lupus erythematosus	4.91e-06	0.000108	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—NAT2—systemic lupus erythematosus	4.91e-06	0.000108	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	4.9e-06	0.000108	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—VEGFA—systemic lupus erythematosus	4.87e-06	0.000107	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.85e-06	0.000107	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.84e-06	0.000106	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NCF2—systemic lupus erythematosus	4.78e-06	0.000105	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—CD4—systemic lupus erythematosus	4.76e-06	0.000105	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	4.75e-06	0.000105	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—VEGFA—systemic lupus erythematosus	4.75e-06	0.000104	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.74e-06	0.000104	CbGpPWpGaD
Indomethacin—SLCO1B1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	4.72e-06	0.000104	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—PTGS2—systemic lupus erythematosus	4.72e-06	0.000104	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—IL6—systemic lupus erythematosus	4.7e-06	0.000103	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—JAK1—systemic lupus erythematosus	4.62e-06	0.000102	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—PTGS2—systemic lupus erythematosus	4.6e-06	0.000101	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.59e-06	0.000101	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.57e-06	0.000101	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—RXRA—systemic lupus erythematosus	4.55e-06	0.0001	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	4.55e-06	0.0001	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—F2—systemic lupus erythematosus	4.55e-06	0.0001	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—ALB—systemic lupus erythematosus	4.52e-06	9.95e-05	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—IL2—systemic lupus erythematosus	4.51e-06	9.92e-05	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—EP300—systemic lupus erythematosus	4.5e-06	9.9e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	4.49e-06	9.87e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—CDKN1B—systemic lupus erythematosus	4.47e-06	9.84e-05	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—TGFB1—systemic lupus erythematosus	4.47e-06	9.83e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.42e-06	9.72e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—JAK1—systemic lupus erythematosus	4.41e-06	9.72e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CD80—systemic lupus erythematosus	4.36e-06	9.6e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PPARG—systemic lupus erythematosus	4.36e-06	9.59e-05	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—TGFB1—systemic lupus erythematosus	4.36e-06	9.59e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.34e-06	9.56e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	4.33e-06	9.53e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—NOS3—systemic lupus erythematosus	4.32e-06	9.51e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—IL2RA—systemic lupus erythematosus	4.31e-06	9.48e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—RXRA—systemic lupus erythematosus	4.25e-06	9.35e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—RXRA—systemic lupus erythematosus	4.25e-06	9.35e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.22e-06	9.3e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCR5—systemic lupus erythematosus	4.18e-06	9.21e-05	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—TNF—systemic lupus erythematosus	4.17e-06	9.18e-05	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	4.17e-06	9.17e-05	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	4.16e-06	9.16e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—CDKN1A—systemic lupus erythematosus	4.13e-06	9.08e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL2RA—systemic lupus erythematosus	4.12e-06	9.07e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—JAK1—systemic lupus erythematosus	4.11e-06	9.06e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	4.1e-06	9.03e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—RXRA—systemic lupus erythematosus	4.1e-06	9.02e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL2—systemic lupus erythematosus	4.09e-06	9e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	4.09e-06	9e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—C3—systemic lupus erythematosus	4.09e-06	9e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CCL2—systemic lupus erythematosus	4.06e-06	8.92e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—NAT2—systemic lupus erythematosus	3.97e-06	8.74e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PTGS2—systemic lupus erythematosus	3.95e-06	8.7e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.94e-06	8.68e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—EP300—systemic lupus erythematosus	3.93e-06	8.64e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—ALB—systemic lupus erythematosus	3.92e-06	8.62e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.9e-06	8.58e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CCR5—systemic lupus erythematosus	3.9e-06	8.58e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—RXRA—systemic lupus erythematosus	3.89e-06	8.57e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.86e-06	8.5e-05	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—EP300—systemic lupus erythematosus	3.82e-06	8.42e-05	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	3.82e-06	8.41e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.8e-06	8.37e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	3.77e-06	8.29e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—F2—systemic lupus erythematosus	3.75e-06	8.26e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—NOS3—systemic lupus erythematosus	3.75e-06	8.25e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—JUNB—systemic lupus erythematosus	3.75e-06	8.25e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TYK2—systemic lupus erythematosus	3.68e-06	8.1e-05	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—IL6—systemic lupus erythematosus	3.65e-06	8.03e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—NOS3—systemic lupus erythematosus	3.61e-06	7.95e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.61e-06	7.95e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—F2—systemic lupus erythematosus	3.59e-06	7.9e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NAT2—systemic lupus erythematosus	3.56e-06	7.84e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	3.52e-06	7.74e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.51e-06	7.72e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	3.48e-06	7.65e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—RXRA—systemic lupus erythematosus	3.46e-06	7.63e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PRL—systemic lupus erythematosus	3.45e-06	7.6e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CD80—systemic lupus erythematosus	3.44e-06	7.57e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PTGS2—systemic lupus erythematosus	3.43e-06	7.54e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—TGFB1—systemic lupus erythematosus	3.41e-06	7.51e-05	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—IL6—systemic lupus erythematosus	3.37e-06	7.41e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PPARG—systemic lupus erythematosus	3.3e-06	7.27e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PPARG—systemic lupus erythematosus	3.3e-06	7.27e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—EP300—systemic lupus erythematosus	3.29e-06	7.24e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	3.25e-06	7.15e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.21e-06	7.07e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CD80—systemic lupus erythematosus	3.21e-06	7.06e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCL2—systemic lupus erythematosus	3.2e-06	7.04e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.15e-06	6.94e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.13e-06	6.89e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL2—systemic lupus erythematosus	3.06e-06	6.74e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—NOS3—systemic lupus erythematosus	2.98e-06	6.56e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—ALB—systemic lupus erythematosus	2.97e-06	6.53e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—ALB—systemic lupus erythematosus	2.97e-06	6.53e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TYK2—systemic lupus erythematosus	2.9e-06	6.39e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MMP9—systemic lupus erythematosus	2.9e-06	6.38e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.89e-06	6.36e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PPARG—systemic lupus erythematosus	2.88e-06	6.33e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NOS3—systemic lupus erythematosus	2.85e-06	6.27e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—EP300—systemic lupus erythematosus	2.85e-06	6.27e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—NOS3—systemic lupus erythematosus	2.84e-06	6.25e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—NOS3—systemic lupus erythematosus	2.84e-06	6.25e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.83e-06	6.23e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—ALB—systemic lupus erythematosus	2.81e-06	6.18e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—JAK1—systemic lupus erythematosus	2.76e-06	6.08e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—RXRA—systemic lupus erythematosus	2.75e-06	6.05e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—EP300—systemic lupus erythematosus	2.75e-06	6.05e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—TYK2—systemic lupus erythematosus	2.71e-06	5.96e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—NOS3—systemic lupus erythematosus	2.69e-06	5.91e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PPARG—systemic lupus erythematosus	2.68e-06	5.91e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PPARG—systemic lupus erythematosus	2.68e-06	5.91e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NOS3—systemic lupus erythematosus	2.66e-06	5.85e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CCR5—systemic lupus erythematosus	2.62e-06	5.76e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.6e-06	5.73e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTGS2—systemic lupus erythematosus	2.6e-06	5.72e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTGS2—systemic lupus erythematosus	2.6e-06	5.72e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PPARG—systemic lupus erythematosus	2.59e-06	5.69e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—ALB—systemic lupus erythematosus	2.59e-06	5.69e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.58e-06	5.68e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—IL6—systemic lupus erythematosus	2.57e-06	5.66e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.55e-06	5.61e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.55e-06	5.6e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—IL2—systemic lupus erythematosus	2.53e-06	5.56e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.48e-06	5.46e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—NOS3—systemic lupus erythematosus	2.47e-06	5.44e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.47e-06	5.44e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PPARG—systemic lupus erythematosus	2.46e-06	5.41e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTGS2—systemic lupus erythematosus	2.46e-06	5.41e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CD4—systemic lupus erythematosus	2.45e-06	5.39e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTGS2—systemic lupus erythematosus	2.43e-06	5.35e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL2—systemic lupus erythematosus	2.42e-06	5.32e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—ALB—systemic lupus erythematosus	2.41e-06	5.31e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—ALB—systemic lupus erythematosus	2.41e-06	5.31e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL6—systemic lupus erythematosus	2.41e-06	5.29e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.39e-06	5.26e-05	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.36e-06	5.2e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ALB—systemic lupus erythematosus	2.33e-06	5.12e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.32e-06	5.11e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—NOS3—systemic lupus erythematosus	2.31e-06	5.08e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—NOS3—systemic lupus erythematosus	2.31e-06	5.08e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CDKN1B—systemic lupus erythematosus	2.3e-06	5.07e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MMP9—systemic lupus erythematosus	2.29e-06	5.03e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.28e-06	5.02e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—EP300—systemic lupus erythematosus	2.27e-06	4.99e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTGS2—systemic lupus erythematosus	2.26e-06	4.98e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.23e-06	4.9e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—NOS3—systemic lupus erythematosus	2.23e-06	4.9e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—RXRA—systemic lupus erythematosus	2.23e-06	4.9e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ALB—systemic lupus erythematosus	2.21e-06	4.87e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	2.19e-06	4.81e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—EP300—systemic lupus erythematosus	2.17e-06	4.77e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—EP300—systemic lupus erythematosus	2.16e-06	4.75e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—EP300—systemic lupus erythematosus	2.16e-06	4.75e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CD80—systemic lupus erythematosus	2.15e-06	4.74e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VEGFA—systemic lupus erythematosus	2.15e-06	4.73e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CDKN1A—systemic lupus erythematosus	2.12e-06	4.68e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—NOS3—systemic lupus erythematosus	2.12e-06	4.65e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTGS2—systemic lupus erythematosus	2.11e-06	4.65e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTGS2—systemic lupus erythematosus	2.11e-06	4.65e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.06e-06	4.54e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.05e-06	4.52e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—EP300—systemic lupus erythematosus	2.04e-06	4.5e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTGS2—systemic lupus erythematosus	2.04e-06	4.48e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.03e-06	4.47e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—EP300—systemic lupus erythematosus	2.02e-06	4.45e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—RXRA—systemic lupus erythematosus	2e-06	4.4e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TGFB1—systemic lupus erythematosus	1.97e-06	4.34e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ALB—systemic lupus erythematosus	1.97e-06	4.33e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	1.95e-06	4.29e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTGS2—systemic lupus erythematosus	1.93e-06	4.26e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.89e-06	4.15e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	1.88e-06	4.14e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—EP300—systemic lupus erythematosus	1.88e-06	4.14e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.85e-06	4.08e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	1.82e-06	4.01e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TYK2—systemic lupus erythematosus	1.82e-06	4e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL6—systemic lupus erythematosus	1.8e-06	3.96e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOS3—systemic lupus erythematosus	1.78e-06	3.93e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—TGFB1—systemic lupus erythematosus	1.76e-06	3.87e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—EP300—systemic lupus erythematosus	1.76e-06	3.86e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—EP300—systemic lupus erythematosus	1.76e-06	3.86e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PPARG—systemic lupus erythematosus	1.74e-06	3.82e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	1.72e-06	3.79e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—EP300—systemic lupus erythematosus	1.69e-06	3.73e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.69e-06	3.72e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CD4—systemic lupus erythematosus	1.64e-06	3.62e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—EP300—systemic lupus erythematosus	1.61e-06	3.54e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ALB—systemic lupus erythematosus	1.56e-06	3.44e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CDKN1B—systemic lupus erythematosus	1.55e-06	3.4e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—NOS3—systemic lupus erythematosus	1.49e-06	3.29e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—EP300—systemic lupus erythematosus	1.43e-06	3.15e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CDKN1A—systemic lupus erythematosus	1.43e-06	3.14e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL6—systemic lupus erythematosus	1.42e-06	3.13e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPARG—systemic lupus erythematosus	1.41e-06	3.09e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EP300—systemic lupus erythematosus	1.36e-06	2.99e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IL6—systemic lupus erythematosus	1.32e-06	2.91e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPARG—systemic lupus erythematosus	1.26e-06	2.78e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	1.23e-06	2.71e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—NOS3—systemic lupus erythematosus	1.21e-06	2.66e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TGFB1—systemic lupus erythematosus	1.18e-06	2.6e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	1.15e-06	2.53e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—EP300—systemic lupus erythematosus	1.14e-06	2.5e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ALB—systemic lupus erythematosus	1.13e-06	2.5e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ALB—systemic lupus erythematosus	1.11e-06	2.44e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS2—systemic lupus erythematosus	1.11e-06	2.43e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NOS3—systemic lupus erythematosus	1.08e-06	2.39e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	1.06e-06	2.33e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	1.03e-06	2.28e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS2—systemic lupus erythematosus	9.92e-07	2.18e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	9.89e-07	2.18e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	9.68e-07	2.13e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—EP300—systemic lupus erythematosus	9.19e-07	2.02e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	9.05e-07	1.99e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6—systemic lupus erythematosus	8.89e-07	1.96e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—EP300—systemic lupus erythematosus	8.25e-07	1.82e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—EP300—systemic lupus erythematosus	8.05e-07	1.77e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	7.52e-07	1.66e-05	CbGpPWpGaD
